Main Authors: | Roberto Ravasio, Silvia Antonelli, Veronica Rogai, Walid Fakhouri, Jean Philippe Capron, Serena Losi |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2018-07-01
|
Series: | Global & Regional Health Technology Assessment |
Online Access: | https://journals.aboutscience.eu/index.php/grhta/article/view/435 |
Similar Items
-
Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy
by: Roberto Ravasio, et al.
Published: (2018-07-01) -
Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib
by: Valentina Perrone, et al.
Published: (2020-07-01) -
Treatment Patterns and Pharmacoutilization in Patients Affected by Rheumatoid Arthritis in Italian Settings
by: Valentina Perrone, et al.
Published: (2021-05-01) -
by: Roberto Ravasio, et al.
Published: (2019-01-01) -
Cost per responder for ixekizumab and other biologic drugs approved for the treatment of moderate-to-severe plaque psoriasis in Italy
by: Roberto Ravasio, et al.
Published: (2019-01-01)